TNSN97109A1 - Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire - Google Patents

Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire

Info

Publication number
TNSN97109A1
TNSN97109A1 TNTNSN97109A TNSN97109A TNSN97109A1 TN SN97109 A1 TNSN97109 A1 TN SN97109A1 TN TNSN97109 A TNTNSN97109 A TN TNSN97109A TN SN97109 A TNSN97109 A TN SN97109A TN SN97109 A1 TNSN97109 A1 TN SN97109A1
Authority
TN
Tunisia
Prior art keywords
virus
avian
vector
vaccine
infectious laryngotracheitis
Prior art date
Application number
TNTNSN97109A
Other languages
English (en)
Inventor
Audonnet Jean-Christophe
Bublot Michel
Riviere Michel
Original Assignee
Rhone Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Merieux filed Critical Rhone Merieux
Publication of TNSN97109A1 publication Critical patent/TNSN97109A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LE VACCIN VIVANT RECOMBINANT AVIAIRE COMPREND, COMME VECTEUR, UN VIRUS ILTV COMPRENANT ET EXPRIMANT AU MOINS UNE SEQUENCE NUCLEOTIDIQUE HETEROLOGUE. CETTE SEQUENCE NUCLEOTIDIQUE ETANT INSERE DANS LE LOCUS D'INSERTION DEFINI ENTRE LES NUCLEOTIDES 1624 ET 3606 A LA SEQ ID NO : 5. LE VACCIN PEUT NOTAMMENT COMPRENDRE UNE SEQUENCE CODANT POUR UN ANTIGENE D'UN AGENT PATHOGENE AVIAIRE CHOISI PARMI LE GROUPE CONSISTANT EN LE VIRUS DE LA MALADIE DE NEWCASTLE (NDV), LE VIRUS DE LA MALADIE GUMBORO (IBDV), LE VIRUS DE LA MALADIE DE MAREK (MDV), LE VIRUS DE LA BRONCHITE INFECTUEUSE (IBV), LE VIRUS DE L'AMENIE DU POULET (CAV), LE VIRUS DE LA PNEUMOVIROSE DU POULET, DE PREFERENCE, SOUS LE CONTROLE D'UN PROMOTEUR EUCARYOTE FORT. FORMULE DE VACCIN MULTIVALENT.
TNTNSN97109A 1996-06-27 1997-06-25 Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire TNSN97109A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608243A FR2750866B1 (fr) 1996-06-27 1996-06-27 Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire

Publications (1)

Publication Number Publication Date
TNSN97109A1 true TNSN97109A1 (fr) 2005-03-15

Family

ID=9493649

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN97109A TNSN97109A1 (fr) 1996-06-27 1997-06-25 Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire

Country Status (13)

Country Link
US (1) US6153199A (fr)
EP (1) EP0914458A1 (fr)
JP (1) JP2000512844A (fr)
AR (1) AR008620A1 (fr)
AU (1) AU739374B2 (fr)
CO (1) CO4700303A1 (fr)
FR (1) FR2750866B1 (fr)
ID (1) ID18351A (fr)
MA (1) MA24222A1 (fr)
PE (1) PE52599A1 (fr)
TN (1) TNSN97109A1 (fr)
WO (1) WO1997049826A1 (fr)
ZA (1) ZA975618B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913751B2 (en) 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
EP1026246B1 (fr) * 1997-10-03 2006-11-29 Zeon Corporation Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers
AR031405A1 (es) * 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
JP2002356441A (ja) * 2001-03-15 2002-12-13 Akzo Nobel Nv 組換え伝染性喉頭気管炎ウイルスワクチン
US7314715B2 (en) * 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
EA007905B1 (ru) 2001-11-16 2007-02-27 Байоджен Айдек Инк. Полицистронная экспрессия антител
EP2390352A1 (fr) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systemes et procedes pour accroitre la production de proteines et de lait chez des bovins laitiers
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
JP2007525217A (ja) 2004-02-19 2007-09-06 ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ レプチンプロモーター多型及びその使用
CN101208104B (zh) 2005-04-25 2012-10-31 梅瑞尔有限公司 Nipah病毒疫苗
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
JP2009515529A (ja) 2005-11-14 2009-04-16 メリアル リミテッド 腎不全のための遺伝子療法
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
EP2414386B1 (fr) 2009-04-03 2016-01-27 Merial Limited Vaccins aviaires transportés par le virus de la maladie de newcastle
ATE539148T1 (de) 2009-11-30 2012-01-15 United Cancer Res Inst Neuer klon des geflügelpestvirus, herstellung und anwendung bei der medizinischen behandlung von krebs
JP5933451B2 (ja) 2009-12-28 2016-06-08 メリアル リミテッド 組換えｎｄｖ抗原及びその使用
JP2013535214A (ja) * 2010-08-02 2013-09-12 ザ ユニヴァーシティ オブ ジョージア リサーチファウンデーション， インク． 改変された伝染性喉頭気管炎ウイルス（ｉｌｔｖ）およびその使用
WO2012030720A1 (fr) 2010-08-31 2012-03-08 Merial Limited Vaccins contre le virus herpétique à base de vecteurs du virus de la maladie de newcastle
WO2012090073A2 (fr) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Procédés et compositions pour prédire la sensibilité à la chimiothérapie
US20140287931A1 (en) 2011-04-04 2014-09-25 Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
AU2012240240A1 (en) 2011-04-04 2013-05-09 Netherlands Cancer Institute Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
US9216213B2 (en) 2011-04-20 2015-12-22 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
CA2834288A1 (fr) 2011-04-25 2012-11-01 Advanced Bioscience Laboratories, Inc. Proteines tronquees d'enveloppe (env) du vih, procedes et compositions associes a celles-ci
CA2837375C (fr) 2011-06-01 2019-07-16 Merial Limited Administration sans aiguille de vaccins contre le vsrrp
SI2741740T1 (sl) 2011-08-12 2017-08-31 Merial, Inc. Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
WO2013093629A2 (fr) 2011-12-20 2013-06-27 Netherlands Cancer Institute Vaccins modulaires, procédés et compositions qui y sont liés
WO2013138776A1 (fr) 2012-03-16 2013-09-19 Merial Limited Nouveaux procédés pour fournir une immunité de protection à long terme contre la rage chez des animaux, basés sur l'administration d'un flavivirus défectueux en termes de réplication, exprimant la rage g
EP2922465A4 (fr) 2012-11-21 2016-07-06 Cardiomems Inc Dispositifs, systèmes et méthodes d'évaluation et de traitement de l'hypertension artérielle pulmonaire (htap)
EP2968514A1 (fr) 2013-03-12 2016-01-20 Merial, Inc. Compositions vaccinales contre le virus de schmallenberg obtenues par génétique inverse, et leurs méthodes d'utilisation
WO2014145712A1 (fr) 2013-03-15 2014-09-18 Cardiomems, Inc. Méthodes de traitement d'états cardiovasculaires
EP2845904A1 (fr) * 2013-09-06 2015-03-11 Ceva Sante Animale Virus de l'herpes de la volaille recombinants et leurs utilisations
EP3215188A1 (fr) 2014-11-03 2017-09-13 Merial, Inc. Procédés d'utilisation de formulations de vaccin par micro-aiguilles pour éliciter une immunité de protection contre le virus de la rage chez les animaux
AU2016282772B2 (en) 2015-06-23 2019-09-05 Boehringer Ingelheim Animal Health USA Inc. PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002802A2 (fr) * 1988-09-13 1990-03-22 Institute For Animal Health Limited Sequences de nucleotides virales
WO1992003554A1 (fr) * 1990-08-24 1992-03-05 Arthur Webster Pty. Ltd. Vaccin contre le virus de la laryngotracheite infectieuse
WO1993025655A1 (fr) * 1992-06-12 1993-12-23 Genencor International, Inc. Compositions enzymatiques et procedes de production d'un aspect lave par abrasion sur du tissu denim teinte par indigo
AU2946395A (en) * 1994-06-30 1996-01-25 Board of Regents of the University of Illinois, The Recombinant infectious laryngotracheitis virus and vaccine
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
EP0822980A4 (fr) * 1995-03-23 2000-04-26 Syntro Corp Virus de la laryngotracheite infectieuse recombine et ses utilisations

Also Published As

Publication number Publication date
ZA975618B (en) 1998-12-28
FR2750866A1 (fr) 1998-01-16
PE52599A1 (es) 1999-07-16
JP2000512844A (ja) 2000-10-03
FR2750866B1 (fr) 1998-11-27
CO4700303A1 (es) 1998-12-29
WO1997049826A1 (fr) 1997-12-31
MA24222A1 (fr) 1997-12-31
ID18351A (id) 1998-04-02
US6153199A (en) 2000-11-28
AR008620A1 (es) 2000-02-09
EP0914458A1 (fr) 1999-05-12
AU3448797A (en) 1998-01-14
AU739374B2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
TNSN97109A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
TNSN98015A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngottracheite infectieuse aviaire
EP1403375A3 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpès aviaire
TNSN97207A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
AU711815B2 (en) Recombinant herpesvirus of turkeys and uses thereof
US5928648A (en) Recombinant herpesvirus of turkeys and uses thereof
HUP9902790A2 (hu) Madarakban alkalmazható polinukleotid-vakcinakészítmények
EP1298139A3 (fr) Vaccin récombinant contre la bursite infectieuse basé sur un virus herpès aviaire
US5961982A (en) Recombinant herpesvirus of turkeys and uses thereof
EP0728842A2 (fr) Vaccin vivant recombinant aviaire à base de virus herpès aviaire, notamment contre la maladie de gumboro
EP1026246A4 (fr) Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers
AU3891897A (en) A method for generating birnavirus from synthetic rna transcripts
AU696247B2 (en) Recombinant fowlpox viruses and uses thereof
WO1991016925A1 (fr) Sequences d'adn specifiques relatives a une proteine du virus de la maladie de la bourse de fabricius comprenant des vecteurs, des hotes et des vaccins
WO1994019014A9 (fr) Avipox virus recombine s-fpv-043 et ses utilisations
CA2223591A1 (fr) Virus de variole aviaire recombines et leurs utilisations
DE68912478D1 (de) Rekombinantes Marek-Krankheitsvirus, Verfahren zu seiner Herstellung, und Vakzine.
CA2478081A1 (fr) Vaccins a base d'adn multiples et multivalents in ovo
MX9702769A (es) Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.
US5925358A (en) Recombinant fowlpox viruses and uses thereof
ECSP972164A (es) Vacunas de uso aviario a base de virus de laringotraqueitis infecciosa
AU727278B2 (en) Recombinant fowlpox viruses and uses thereof II
TH25170A (th) รีคอมบิแนนท์วัคซีนของนกชนิดที่มีชีวิตโดยใช้เฮอร์ปีส์ไวรัสของนกเป็นเวกเตอร์
Morgan et al. Recombinant vaccine against Marek's disease
WO1999055860A8 (fr) Proteine codee par l'hote exprimee dans des cellules infectees par le virus de la maladie de marek (mdv) et anticorps dirige contre celle-ci